
## **Trustees’ Annual Report for the period** 

## **From  April 2023                  Period start date   To March 2024        Period end date** 

## **Charity name: Beds Prostate Cancer Support Group** 

## **Charity registration number:  1174019** 

## **Objectives and Activities** 

||SORP reference||
|---|---|---|
|Summary of the purposes of<br>the charity as set out in its<br>governing document|Para 1.17|**To support men in Bedfordshire**<br>**diagnosed or treated for Prostate**<br>**Cancer**|
|Summary of the main<br>activities in relation to those<br>purposes for the public<br>benefit, in particular, the<br>activities, projects or<br>services identified in the<br>accounts.|Para 1.17 and<br>1.19|**To carry out PSA testing events, to**<br>**provide home testing kits and to**<br>**promote awareness of the risks of**<br>**prostate cancer**|
|Statement confirming<br>whether the trustees have<br>had regard to the guidance<br>issued by the Charity<br>Commission on public<br>benefit|Para 1.18|**Undertaking 3 testing events in north,**<br>**mid and south Bedfordshire.**<br>**Trustees have due regard to the**<br>**guidance.**|



## **Additional information (optional)** You may choose to include further statements where relevant about: 

SORP reference **N/A** Para 1.38 Policy on grant making **N/A** Para 1.38 Policy on social investment including program related investment **N/A** Para 1.38 Contribution made by volunteers **N/A** Other 



## **Achievements and Performance** 

||SORP reference||
|---|---|---|
|Summary of the main<br>achievements of the charity,<br>identifying the difference the<br>charity’s work has made to<br>the circumstances of its<br>beneficiaries and any wider<br>benefits to society as a<br>whole.|Para 1.20|**905 men were tested throughout**<br>**Bedfordshire for prostate cancer.**<br>**30 men were identified with the disease.**<br>**18men were identified as possibly**<br>**having the disease.**<br>**Early detection means treatment can**<br>**lead to the disease being manged or**<br>**cured.**|
|**Additional information (optional)**<br>You may choose to include further statements||where relevant about:|
|Achievements against<br>objectives set|Para 1.41|**The objective is to carry out 3 PSA**<br>**testing events each year in the north,**<br>**mid and south Bedfordshire which was**<br>**achieved.**|
|Performance of fundraising<br>activities against objectives<br>set|Para 1.41|**Fundraising is achieved at the PSA**<br>**testing events.  Donations are made**<br>**from groups, clubs and individuals**<br>**throughout the year.**|
|Investment performance<br>against objectives|Para 1.41|**N/A**|
|Other||**Monthly meetings are held to allow men**<br>**to share their treatments or diagnosis**|





## **Financial Review** 

|**Financial Review**|||
|---|---|---|
|Review of the charity’s<br>financial position at the end<br>of the period|Para 1.21|**The charity had a closing balance of**<br>**£47245**|
|Statement explaining the<br>policy for holding reserves<br>stating why they are held|Para 1.22|**N/A**|
|Amount of reserves held|Para 1.22|**N/A**|
|Reasons for holding zero<br>reserves|Para 1.22|**Monies are held in a current account to**<br>**provide instant access**|
|Details of fund materially in<br>deficit|Para 1.24|**None**|
|Explanation of any<br>uncertainties about the<br>charity continuing as a going<br>concern|Para 1.23|**The Chairman died in December 2022**<br>**and nobody has come forward to**<br>**replace him.  The Secretary and**<br>**Treasurer will resign in July 2024.  The**<br>**intention is for these officers and the**<br>**committee to form a charitable trust to**<br>**continue with 3 x PSA testing events**<br>**and serve as trustees.  All awareness**<br>**events, promotion and presentations**<br>**will cease.**|



## **Additional information (optional)** You may choose to include further statements where relevant about: 

||||
|---|---|---|
|The charity’s principal<br>sources of funds (including<br>any fundraising)|Para 1.47|**Donations from groups, clubs and**<br>**individuals in Bedfordshire**|
|Investment policy and<br>objectives including any<br>social investment policy<br>adopted|Para 1.46|**N/A**|
|A description of the principal<br>risks facing the charity|Para 1.46|**Nobody coming forward to serve as**<br>**Chairman, secretary and Treasurer to**<br>**replace the retirees from these roles.**|
|Other||**N/A**|





## **Structure, Governance and Management** 

|Description of charity’s<br>trusts:|||
|---|---|---|
|Type of governing document<br>(trust deed, royal charter)|Para 1.25|**Constitution**|
|How is the charity<br>constituted?<br>(e.g unincorporated<br>association, CIO)|Para 1.25|**CIO**|
|Trustee selection methods<br>including details of any<br>constitutional provisions e.g.<br>election to post or name of<br>any person or body entitled<br>to appoint one or more<br>trustees|Para 1.25|**Volunteers are invited to attend one of**<br>**the monthly meetings to explain and be**<br>**quizzed about their reasons for**<br>**volunteering.**|



**Additional information (optional)** You may choose to include further statements where relevant about: 

|Policies and procedures<br>adopted for the induction<br>and training of trustees|Para 1.51|**N/A**|
|---|---|---|
|The charity’s organisational<br>structure and any wider<br>network with which the<br>charity works|Para 1.51|**Treasurer**<br>**Secretary**<br>**Committee members x 4**|
|Relationship with any<br>related parties|Para 1.51|**Affiliated to PCUK and Macmillan**|
|Other||**N/A**|



## **Reference and Administrative details** 

|Charity name|**Beds Prostate Cancer Support Group**|
|---|---|
|Other name the charity uses|**BPCSG**|
|Registered charity number|**1174019**|
|Charity’s principal address|**5 Kimbolton Close**<br>**Bedford**<br>**MK41 8RP**|
|||





## **Names of the charity trustees who manage the charity** 

|1<br>2<br>3<br>4<br>5<br>6<br>7<br>8<br>9<br>10<br>11<br>12<br>13<br>14<br>15<br>16<br>17<br>18<br>19<br>20|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**<br>**year **|**Name of person (or body) entitled**<br>**to appoint trustee (ifany)**|
|---|---|---|---|---|
||Jim Francis|Treasurer|Wholeyear|Committee|
||Steve Pearce|Secretary|Wholeyear|Committee|
||Stephen Jarvis|Committee member|Wholeyear|Committee|
||Barbara Dainton|Committee member|Wholeyear|Committee|
||John Dixon|Committee member|Wholeyear|Committee|
||Rob Bottley|Committee member|December 2022|Committee|
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||



## – Corporate trustees names of the directors at the date the report was approved 

**Director name** 

## Name of trustees holding title to property belonging to the charity 

**Trustee name Dates acted if not for whole year** 



## **Funds held as custodian trustees on behalf of others** 

Description of the assets held in this capacity 

Name and objects of the charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for safe custody and segregation of such assets from the charity’s own assets 

## **Additional information (optional)** 

## **Names and addresses of advisers (Optional information)** 

|**Type of**|**Name**|**Address**|
|---|---|---|
|**adviser**|||



**Name of chief executive or names of senior staff members (Optional information)** 

## **Exemptions from disclosure** 

Reason for non-disclosure of key personnel details 

## **Other optional information** 



## 

## 

|**Signature(s)**|||
|---|---|---|
|**Full name(s)**|Stephen Pearce|Jim Francis|
|**Position (eg Secretary,**|Secretary|Treasurer|
|**Chair, etc)**L­___________-----L_____________---'|||
|**Date**117/06/2024|||






|**Charity Name**|||**No (if any)**|
|---|---|---|---|
|**Receipts andpayments accounts**||||
|**For the period**<br>**from**|Period start date|**To**|Period end date|



**CC16a** 

## **Section A Receipts and payments** 

|**A1 Receipts**|**Unrestricted**<br>**funds**<br>**to the nearest**<br>**£**<br>**34,469**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**34,469**<br>**-**<br>**-**<br>**-**<br>**34,469**<br>**16,185**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br> **16,185**<br>**-**<br>**-**<br> **-**<br>**16,185**<br>**18,284**<br>**-**<br>**-**<br>**18,284**|**Restricted**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to the nearest £**|**Total funds**<br>**to the nearest £**<br>**34,469**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**34,469**<br>**-**<br>**-**<br>**-**<br>**34,469**<br>**16,185**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**16,185**<br>**-**<br>**-**<br>**-**<br>**16,185**<br> <br>**18,284**|**Last year**<br>**to the nearest £**|
|---|---|---|---|---|---|
||**34,469**||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**||**21,947**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|
||**-**|||||
||**-**|||||
||**-**|||||
||**-**|||||
||**-**|||||
||**-**|||||
||**-**|||||
|**_Sub total_**_(Gross income for_<br>_AR)_|**34,469**||||**21,947**|
|||||||
|**A2 Asset and investment sales,**<br>**(see table).**||||||
||**-**||**-**<br>**-**<br>**-**||**-**|
||**-**|||||
|**_Sub total_**|**-**||||**-**|
|**_Total receipts_**<br>**A3 Payments**||||||
||||**-**||**21,947**|
|||||||
||**16,185**||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**||**17,666**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|
||**-**|||||
||**-**|||||
||**-**|||||
||**-**|||||
||**-**|||||
||**-**|||||
||**-**|||||
||**-**|||||
|**_Sub total_ **|**16,185**||||**17,666**|
|||||||
|**A4 Asset and investment**<br>**purchases, (see table)**||||||
||**-**||**-**<br>**-**<br>**-**|||
||**-**|||||
|**_Sub total_ **|**-**||||**-**|
|**_Total payments_**<br>**_Net of receipts/(payments)_**<br>**A5 Transfers between funds**<br>**A6 Cash funds last year end**<br>**_Cash funds this year end_**||||||
||||**-**||**17,666**|
|||||||
||**18,284**|**-**|**-**||**4,281**|
||**-**|**-**|**-**<br>**-**|**-**<br>**-**|**-**<br>**-**|
||**-**|**-**||||
||**18,284**|**-**|**-**|**18,284**|**4,281**|



CCXX R1 accounts (SS) 

01/07/2024 

1 



|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**||
|---|---|---|---|---|
|**Categories**<br>**B3 Investment assets**<br>**B2 Other monetary assets**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>**B1 Cash funds**|**Details**<br>**Details**<br>**Details**<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))<br>**Details**|**Unrestricted**<br>**funds**<br>**to nearest £**<br>**47,245**<br>**-**<br>**-**<br>**47,245**<br>Agreement Error<br>**Unrestricted**<br>**funds**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**asset belongs**|**Restricted**<br>**funds**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>OK<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to nearest £**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||OK|
|||||**Endowment**<br>**funds**<br>**to nearest £**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**Current value**<br>**(optional)**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**Current value**<br>**(optional)**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|
||||**-**|**-**|



CCXX R2 accounts (SS) 

01/07/2024 

2 




